Blacks Less Likely to Get Screening Follow-up

African Americans get more colorectal cancer than whites and die more often.

Whether this is because of different biology or lack of access to high-quality medical care has long been debated.

In a new study, blacks had very similar rates of polyps found during a screening flexible sigmoidoscopy.  But they were less likely to get a recommended follow-up colonoscopy.

While about 1 in 4 people had polyps discovered during their sigmoidoscopy, nearly identical percentages for blacks and whites, blacks got colonoscopy follow-up about 12 percent less often than whites.

For those who did get a colonoscopy, adenomas and advanced adenomas were just as likely in whites and blacks, as was the rate of cancers discovered.

The Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial screened 60,572 people for colorectal cancer using flexible sigmoidoscopy.  Doctors recommended those who had abnormalities discovered during the screening test have a colonoscopy.  However, the trial did not pay for the follow-up exam.

Analysis of the PLCO trial found,

Lead author Adeyinka O. Laiyemo, MD, MPH, from Howard University School of Medicine, and colleagues concluded,

We observed a lower follow-up for screen-detected abnormalities among blacks when compared with whites but little difference in the yield of colorectal neoplasia. Health-care utilization may be playing more of a role in colorectal cancer racial disparity than biology.

The study did not look at reasons that African Americans were less likely to get follow-up colonoscopies.  However, in an editorial accompanying the study results in the Journal of the National Cancer Institute, John Z. Ayanian, MD, MPP, from the Department of Health Care Policy discussed some potential barriers to follow-up care.

He pointed out that other research has shown:

The barriers concerned Dr. Ayanian, who wrote,

These gaps in follow-up care were particularly concerning because up to one-quarter of participants who did not undergo colonoscopy were likely to have advanced adenomas that were neither detected nor removed. Valuable opportunities to prevent colorectal cancer were thus lost in these patients.

He called for programs like that in New York City which increased colonoscopy screening rates for black adults from 35 percent to 64 percent in four years to be expanded to other communities.  The program in New York uses public education, improved tracking systems, and patient navigators to get low-income people to screening.  He also cited the expanded Centers for Disease Control and Prevention program that will promote colorectal cancer screening for low-income Americans in 22 states and four tribal organizations.

He said,

Colorectal cancer is one important disease in which racial and socioeconomic disparities in outcomes can most readily be eliminated by ensuring that all eligible adults are effectively screened and abnormal findings are fully treated.

SOURCES:

Laiyemo et al., Journal of the National Cancer Institute, Advance Access, March 31, 2010.

John Z. Ayanian, Racial Disparities in Outcomes of Colorectal Cancer Screening: Biology or Barriers to Optimal Care?, Journal of the National Cancer Institute, Advance Access, March 31, 2010.

Bookmark and Share

This news article was originally posted on April 8th, 2010 and was accurate at the time of publication. Since then, information may have changed or links may now be outdated. Please call our Answer Line 1-877-427-2111 for the latest information, or talk to your doctor before making any medical decisions.

Posted by Kate Murphy on April 8th, 2010
Tags: colorectal cancer screening, disparities

Leave a Comment Comments RSS

Your comments are welcome. However, specific medical advice will not be provided, and we urge you to consult with a qualified physician for diagnosis and for answers to your personal questions. C3 is not responsible for the medical accuracy of any comments left by persons other than C3 staff members. C3 staff members monitor comments and may respond publicly where appropriate.

Please note that we automatically publish the name that you enter next to your post. Also note that our pages are automatically indexed by Google and other search engines, and your name may therefore appear in search results on those sites. So if you wish to remain anonymous please use a different name or enter 'Anon' as the name.

We regret that we are unable to privately answer questions left as comments. So please do not include your phone number, email or mailing address in the body of your comment. For the best personal and direct response to your colorectal cancer treatment questions, please call our Answer Line at 1-877-4CRC-111 (1-877-427-2111).

Search C3

Register to receive our free e-newsletter

Get monthly updates on colorectal cancer treatment options, research news and advocacy opportunities. We promise to not bombard you with email - just enough to keep you informed on how to fight colorectal cancer.

First Name

Last Name

Email

Donate

Support C3 and the Lisa Fund for Research

Donate to C3

Donate to The Lisa Fund

Learn more about the Lisa Fund

Sign Our Petition

Guarantee access to colorectal cancer screening for all Americans who need it.

Get Involved

Subscribe to the C3 website

Get C3 news & updates

Get the latest articles in your email inbox or news reader as soon as they are published.

Subscribe